Back to top
Logo
Print |

Progressions 2007: The Ernst & Young Global Pharmaceutical Report

Leading industry thinkers and Ernst & Young professionals have contributed to "Progressions 2007."

Global industry executives

  • Linda Horton
    Hogan & Hartson LLP
  • Michael McCaughan
    Senior Editor, The RPM Report
  • Gary Uy
    Hogan & Hartson LLP
  • Mamidanna Venkateswarlu
    Drugs Controller General of India, Ministry of Health and Family Welfare

Ernst & Young industry professionals

  • Ted Acosta
  • Howard Brooks
  • Scott Bruns
  • Carolyn Buck Luce
  • Jim Bulkowski
  • Mark Campbell
  • Les Clifford
  • Karoline Dubiel
  • Eileen Erdos
  • Tracee Fultz
  • Christopher Gray
  • Jeffrey Greene
  • Tom Gregory
  • Colm Halpin
  • Frank Kumli
  • Carol Landsman
  • Virginie Lefebvre-Dutilleul
  • Tom Madden
  • Anthony Masherelli
  • Roshan Ramlukan
  • Bhavna Sethi
  • John Smart
  • Kathleen Smith
  • Jeffrey Steinberg
  • Bruce Stump
  • Jerry Wald
  • Melissa Whitman

Global Pharmaceutical Center



To request your own copy of "Progressions 2007" contact your local pharmaceutical representative.


What choices can today’s pharma companies make to balance risks and rewards, avoid major pitfalls, and grow their businesses globally? Global Pharmaceutical Center leaders address these questions in our podcast series "Capturing the global advantage". Visit our US site to subscribe.
Ernst & Young refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global Ernst & Young organization and does not provide any service to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms.